Quarterly report · Q3
9776.TEDINET S100Q4U9
Period2022-04-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.3bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥19.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.3bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥817m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥972m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥891m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.0bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥493m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.0bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥662m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥578m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥660m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥16.9bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥16.1bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥15.5bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.1bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥5.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.8bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.0bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.1bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥147.85 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥70.53 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥306.16 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥193.96 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.83 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 62.2% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.2% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥75m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥73m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥49m |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥6.4bn |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥6.4bn |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥532m |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥601m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥726m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥495m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥8m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥15.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥15.2bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥495m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥15.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥15.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥498m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-12-31 | ¥80m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥79m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥723,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-12-31 | ¥55m |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥5.5bn |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥5.5bn |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥741m |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥7.9bn |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥7.9bn |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥642m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥1.7bn |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥724m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥994m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥12m |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥15.2bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥14.2bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥994m |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥15.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥14.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥995m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥1.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 387
| Item | Context | Value | Unit |
|---|---|---|---|
| Property plant and equipment | Prior1YearInstant | 8127702000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 8016386000 | JPY |
| Other ia | Prior1YearInstant | 60128000 | JPY |
| Other ia | CurrentQuarterInstant | 56070000 | JPY |
| Intangible assets | Prior1YearInstant | 60128000 | JPY |
| Intangible assets | CurrentQuarterInstant | 56070000 | JPY |
| Investment securities | Prior1YearInstant | 142407000 | JPY |
| Investment securities | CurrentQuarterInstant | 144295000 | JPY |
| Long term loans receivable | Prior1YearInstant | 7000 | JPY |
| Long term loans receivable | CurrentQuarterInstant | － | JPY |
| Long term prepaid expenses | Prior1YearInstant | 29916000 | JPY |
| Long term prepaid expenses | CurrentQuarterInstant | 24195000 | JPY |
| Guarantee deposits ioa | Prior1YearInstant | 179172000 | JPY |
| Guarantee deposits ioa | CurrentQuarterInstant | 167595000 | JPY |
| Deferred tax assets | Prior1YearInstant | 162164000 | JPY |
| Deferred tax assets | CurrentQuarterInstant | 163973000 | JPY |
| Other ioa | Prior1YearInstant | 235146000 | JPY |
| Other ioa | CurrentQuarterInstant | 223738000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -16841000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -16841000 | JPY |
| Investments and other assets | Prior1YearInstant | 731974000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 706956000 | JPY |
| Noncurrent assets | Prior1YearInstant | 8919805000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 8779413000 | JPY |
| Assets | Prior1YearInstant | 16149449000 | JPY |
| Assets | CurrentQuarterInstant | 16893292000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 2258565000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 2660258000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 133692000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 135367000 | JPY |
| Lease obligations cl | Prior1YearInstant | 106041000 | JPY |
| Lease obligations cl | CurrentQuarterInstant | 115230000 | JPY |
| Income taxes payable | Prior1YearInstant | 294056000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 109389000 | JPY |
| Provision for bonuses | Prior1YearInstant | 120975000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 31959000 | JPY |
| Accounts payable other | Prior1YearInstant | 125075000 | JPY |
| Accounts payable other | CurrentQuarterInstant | 223679000 | JPY |
| Asset retirement obligations cl | Prior1YearInstant | 28000000 | JPY |
| Asset retirement obligations cl | CurrentQuarterInstant | － | JPY |
| Other cl | Prior1YearInstant | 215389000 | JPY |
| Other cl | CurrentQuarterInstant | 433193000 | JPY |
| Current liabilities | Prior1YearInstant | 3281795000 | JPY |
| Current liabilities | CurrentQuarterInstant | 3709078000 | JPY |
| Long term loans payable | Prior1YearInstant | 1732321000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 1632052000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 610978000 | JPY |
| Lease obligations ncl | CurrentQuarterInstant | 540050000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 66870000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 67104000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |